Based at DCU Invent, Deciphex has gained investors including Inova and GI Partners as it looks to refine its offering for the toxicologic and gastrointestinal segments of pathology.

Deciphex, an Ireland-based automated pathological services provider based at Dublin City University’s Invent incubator, has attracted €2.3m ($2.6m) in a round backed by healthcare provider Inova’s Personalised Health Accelerator.
Inova Personalised Health Accelerator was joined in the round by investors including gastroenterology healthcare provider GI Partners of Illinois, angel network Irrus Investments, VC firm ACT Venture Capital and Nextsteps Ventures.
Founded in 2017, Deciphex has created an artificial intelligence-powered digital pathology platform called Patholytix that automates basic visual…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?